Overview

Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura

Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
To investigate the migraine inducing effect of levcromakalim in patients with migraine with aura.
Phase:
N/A
Details
Lead Sponsor:
Danish Headache Center
Treatments:
Cromakalim